Xifaxan kho mob plab plob tsis so tswj nrog raws plab thiab kab mob siab. Xyoo 2020, Bausch Health Ireland thiab Salix Pharmaceuticals foob Norwich Pharmaceuticals hauv 2020 rau kev ua txhaum cai patent, hais txog Norwich cov phiaj xwm los nqa cov qauv ntawm Xifaxan rau kev ua lag luam ua ntej nws cov patents tau tas sij hawm, raws li ib tug Bloomberg Txoj cai qhia.
Hnub Thursday, Tus Kws Txiav Txim Cai Richard Andrews ntawm Lub Tsev Hais Plaub Hauv Tebchaws Meskas rau Lub Tsev Haujlwm ntawm Delaware tau txiav txim siab tias qee qhov kev thov patent cuam tshuam nrog Xifaxan tsis raug cai, tab sis txhawb nqa lwm tus ntsig txog cov tsos mob ntawm tus kab mob siab, raws li tsab ntawv ceeb toom. Nrog qee cov patents suav tias tsis raug, cov neeg sib tw zoo li Norwich yuav tsum muaj peev xwm mus txuas ntxiv nrog lawv tus kheej generic ntawm Xifaxan yog tias ib qho kev thov los ntawm Bausch Health tsis ua tiav. Bausch Health tsis tau teb tam sim ntawd rau kev thov tawm tswv yim.
Douglas Miehm, tus kws tshuaj ntsuam ntawm RBC Capital Markets tau sau hnub Thursday tias "Yog tias qhov kev txiav txim tsis zoo raug tswj xyuas, Xifaxin generic tuaj yeem nkag mus rau hauv kev lag luam sai li sai tau 2024,"
Alvogen, Norwich lub tuam txhab niam txiv, tau hais hauv tsab ntawv xa email rau Barron tus hais tias nws yog "zoo siab heev rau hauv cheeb tsam tsev hais plaub qhov kev txiav txim siab uas tshem tawm qhov teeb meem tseem ceeb hauv txoj hauv kev los coj txoj kev pheej yig rau cov neeg mob noj Xifaxan rau IBS-D."
Miehm, uas ntsuas cov khoom lag luam ntawm Outperform nrog $ 12 lub hom phiaj tus nqi, ntxiv tias Bausch Health yuav zoo li thov rau US Tsev Hais Plaub Txiav Txim Siab rau Tsoom Fwv Teb Chaws Circuit Court, uas nws tau hais tias tuaj yeem siv sijhawm txog 18 lub hlis ua ntej tshaj tawm qhov kev txiav txim siab ntawm qhov kev thov rov hais dua.
Tus kws tshuaj ntsuam hu ua qhov kev txiav txim "muaj peev xwm ua tau qhov tshwm sim phem tshaj plaws rau BHC." Qhov kev txiav txim siab tuaj yeem ua rau Bausch Health tsoo nws qhov kev poob qis ntawm $ 4 ib feem, nws hais ntxiv.
Ua ntej kev lag luam raug tso tseg nyob ib ncig ntawm 10: 30 teev sawv ntxov hnub Thursday, Bausch Health shares tanked 50.3% rau $ 4.32, uas ua rau cov khoom lag luam nce siab rau nws qhov qis tshaj plaws txij li lub Kaum Ib Hlis 1995, thaum nws kaw ntawm $ 4.15, raws li Dow Jones Market Data. Cov Tshuag tau poob 84% hauv 2022.
Shares ntawm
Bausch + Lomb
(BLCO), lub qhov muag saib xyuas kev noj qab haus huv ntawm Bausch Health uas tau mus rau pej xeem thaum lub Tsib Hlis, poob 6% Hnub Thursday rau $ 15.11, thaum lub
S&P 500
tau txais 1.2%.
Sau rau Angela Palumbo ntawm [email tiv thaiv]
Bausch Kev Noj Qab Haus Huv Tshuag Halted Tom qab patent txiav txim. Dab tsi tshwm sim tom ntej.
Ntawv loj
Tau qhov twg los: https://www.barrons.com/articles/bausch-health-stock-patent-ruling-51659037449?siteid=yhoof2&yptr=yahoo